Financhill
Buy
68

PLX Quote, Financials, Valuation and Earnings

Last price:
$1.76
Seasonality move :
19.62%
Day range:
$1.69 - $1.79
52-week range:
$0.82 - $1.90
Dividend yield:
0%
P/E ratio:
115.00x
P/S ratio:
3.03x
P/B ratio:
4.00x
Volume:
344.3K
Avg. volume:
475.6K
1-year change:
2.92%
Market cap:
$129.6M
Revenue:
$65.5M
EPS (TTM):
-$0.16

Earnings Data

Next earnings date for PLX
Mar 14
2025
Most recent earnings per share
$0.03
Beat by $0.03
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PLX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/14/2025 Q4 $18.2M -- -- -- --
11/14/2024 Q3 $16.3M $18M $0.03 -- --
08/14/2024 Q2 $12.5M $13.5M -$0.03 -- --
05/10/2024 Q1 $9.2M $3.7M -$0.06 -- --
03/14/2024 Q4 $8.1M $10.5M -$0.10 -- --
11/06/2023 Q3 -- -- -$0.04 -- --
08/07/2023 Q2 -- -- $0.21 -- --
05/04/2023 Q1 -- -- -$0.05 -- --
02/27/2023 Q4 -- -- -$0.07 -- --
11/14/2022 Q3 -- -- -$0.07 -- --
08/15/2022 Q2 -- -- -$0.11 -- --
05/16/2022 Q1 -- -- -$0.05 -- --
03/31/2022 Q4 -- -- -$0.14 -- --
11/15/2021 Q3 -- -- -$0.09 -- --
08/16/2021 Q2 -- -- -$0.25 -- --
05/14/2021 Q1 -- -- -$0.14 -- --
03/30/2021 Q4 -- -- $0.03 -- --
10/29/2020 Q3 -- -- -$0.14 -- --
08/10/2020 Q2 -- -- -$0.13 -- --
06/01/2020 Q1 -- -- $0.10 -- --
03/12/2020 Q4 -- -- $0.02 -- --
11/07/2019 Q3 -- -- -$0.24 -- --
08/08/2019 Q2 -- -- -$0.52 -- --
05/06/2019 Q1 -- -- -$0.50 -- --
03/14/2019 Q4 -- -- -$0.40 -- --
11/07/2018 Q3 -- -- -$0.40 -- --
08/09/2018 Q2 -- -- -$0.60 -- --
05/09/2018 Q1 -- -- -$0.50 -- --
03/06/2018 Q4 -- -- -$0.87 -- --
11/08/2017 Q3 -- -- -$0.90 -- --
08/09/2017 Q2 -- -- -$0.60 -- --
05/10/2017 Q1 -- -- -$4.80 -- --
03/16/2017 Q4 -- -- -$0.20 -- --
11/09/2016 Q3 -- -- -$0.70 -- --
08/08/2016 Q2 -- -- -$1.10 -- --
05/09/2016 Q1 -- -- -$0.90 -- --
03/08/2016 Q4 -- -- $7.70 -- --
11/09/2015 Q3 -- -- -$0.40 -- --
08/10/2015 Q2 -- -- -$0.50 -- --
05/07/2015 Q1 -- -- -$0.60 -- --
03/12/2015 Q4 -- -- -$0.90 -- --

Protalix BioTherapeutics Earnings Questions

  • How Much did Protalix BioTherapeutics Generate in Revenue Last Quarter?

    Protalix BioTherapeutics reported $18M worth of top line sales in its most recent quarter.

  • Did Protalix BioTherapeutics Beat Earnings Last Quarter?

    Protalix BioTherapeutics announced earnings per share of $0.03 which represents a beat of analyst forecast a -- per share.

  • Is Protalix BioTherapeutics Profitable?

    Protalix BioTherapeutics reported $9.6M that represents $0.12 per share over the last quarter.

  • What is the Analyst Consensus for Protalix BioTherapeutics EPS Next Year?

    Protalix BioTherapeutics's earnings are forecast to grow from $0.09 per share to -- per share next year representing an increase of --.

  • When is Protalix BioTherapeutics's Earnings Date?

    Protalix BioTherapeutics's next earnings date is March 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock